MRFF - Clinical Trials Activity Initiative - 2026 International Clinical Trial Collaborations Grant Opportunity


Descriptions

Opportunity ID:

OPP0000006011

Opportunity type:

Grant

Sponsor:

Government of Australia / National Health and Medical Research Council

Award amount and duration:

Up to AUD $3,000,000 for up to 7 years

Currency:

AUD

Eligibility

Type:
Faculty

Applications will only be accepted from approved MRFF Eligible Organisations. A list of approved MRFF Eligible Organisations is available from the MRFF Eligible Organisations List on the NHMRC website.

Applications must satisfy all the requirements set out in the Medical Research Future Fund - Clinicial Trials Activity Initiative - 2026 International Clinical Trial Collaborations Grant Opportunity Guidelines. 

Summary

The Medical Research Future Fund (MRFF) Clinical Trials Activity Initiative (the Initiative) aims to increase clinical trial activity in Australia in order to improve the evidence base supporting clinical care and to help patients access trials relevant to their health circumstances and enable researchers to bring international trials to Australian patients.  

The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:  

  • Promote Australian involvement in international collaborative investigator-initiated clinical trials research through the establishment and co-ordination of clinical trial site/s in Australia.
     
  • Provide high-quality evidence of the effectiveness of novel health treatments, drugs or devices in `usual care¿ settings, which will support a decision on whether to deliver the intervention in an Australian setting.


The intended outcome of the research is to improve the health and wellbeing of Australians by investing in new clinical trials that support increased access to high-quality, evidence-based and effective health care.

Applicants to this grant opportunity must propose a clinical trial in Australia in collaboration with international counterparts. The clinical trial should not have commenced recruitment at the Australian trial site/s.

Please note the 2026 MRFF International Clinical Trial Collaborations grant opportunity will be open for one round only.  

This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health, Disability and Ageing. 

 

Overhead

0

Deadlines

Application deadlines

RSO detailed review deadline

Date:
September 1, 2026 - 12:00 PM

RSO final internal review deadline

Date:
September 10, 2026 - 12:00 PM

Program application deadline

Date:
September 16, 2026 - 1:00 AM

Approvals

NOTE: Consult your Faculty Associate Dean (Research) (ADR) regarding Faculty-specific deadlines and submission processes.

Principal Investigators: Complete a Research Management System (RMS) record, including a copy of your complete application, and submit this for approvals in RMS.

Postdocs, students, and trainees: For fellowships and externally-sponsored research training awards or opportunities, you must complete the Research Funding Application Approval (RFAA) Trainee PDF form, and submit it, along with a complete copy of the application, to Research Services at rsotrainee@ucalgary.ca. Trainees should not use RMS at this time.

Approvals: The University of Calgary requires that all funding applications be approved prior to submission. Approval requires signatures via either RMS or the RFAA Trainee form, in the following order:

  • Principal Investigator
  • Department Head
  • Faculty ADR/Dean
  • Research Services (on behalf of the Vice-President Research)

Read the Meaning of Grant Signatures policy to understand what your approval means. Please see the agency guidelines for details about which signatures are required on your application, as it may differ from internal requirements.

Late submissions: Late submissions will only be accepted in cases of medical or family emergencies, or other exceptional circumstances. If you submit your RMS record to Research Services after the internal deadline has passed, you must secure additional approvals. Please read: Late Applications Process.


Additional Information

RESOURCES

Reminder: The sooner the researcher engages with Research Services, the more help we can be!

Contact the following Research Service units for support with:

Projects Involving Indigenous Research:

Support with incorporating wise practices in Indigenous research, community engagement, and Indigenous data management is available through the Indigenous Research Support Team (IRST).

Applicants can reach out by email to IRST at IRST@ucalgary.ca in advance of the RSO internal deadline. For more information about IRST, please visit the IRST webpage.

Knowledge Mobilization, Research Impact Assessment, DORA:

Support for knowledge mobilization/engagement/translation, community partnerships, research impact, responsible research assessment (DORA), and open science, is available through the Knowledge to Impact team.

Applicants can reach out by email to the KI team at knowledge.impact@ucalgary.ca.

For more information and access to resource archives, please visit the KI team webpage.

Research Data Management:

For information on research data management plans, processes, or best practices for your research program, please contact research.data@ucalgary.ca.

EDI in Research:

RSO can provide resources and support to research teams on the integration of equitable and inclusive practices in research design and research practice.

Contact edi.rso@ucalgary.ca for more information.

Research Security:

The Research Security Division is available to ensure researchers adhere to research security guidelines and policies, including the National Security Guidelines for Research Partnerships (NSGRP) and the policy on Sensitive Technology Research and Affiliations of Concern (STRAC).

Visit the Research Security website to learn more or contact researchsecurity@ucalgary.ca.

Pre-Award Submissions:
RMS: Creating a Pre-Award Application


Contact Details


Keywords

CLINICAL TRIALS
COLLABORATIONS
NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL